These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11027850)
1. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Mellick GD; Silburn PA Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850 [TBL] [Abstract][Full Text] [Related]
2. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Xue S; Jia J Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667 [TBL] [Abstract][Full Text] [Related]
3. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset. Wang J; Zhao CY; Si YM; Liu ZL; Chen B; Yu L Mov Disord; 2002 Jul; 17(4):767-71. PubMed ID: 12210873 [TBL] [Abstract][Full Text] [Related]
4. No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease. Levecque C; Destée A; Mouroux V; Becquet E; Defebvre L; Amouyel P; Chartier-Harlin MC J Neural Transm (Vienna); 2001; 108(8-9):979-84. PubMed ID: 11716150 [TBL] [Abstract][Full Text] [Related]
5. An Ile93Met substitution in the UCH-L1 gene is not a disease-causing mutation for idiopathic Parkinson's disease. Shi Q; Tao E Chin Med J (Engl); 2003 Feb; 116(2):312-3. PubMed ID: 12775255 [TBL] [Abstract][Full Text] [Related]
6. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. Satoh J; Kuroda Y J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241 [TBL] [Abstract][Full Text] [Related]
7. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Maraganore DM; Farrer MJ; Hardy JA; Lincoln SJ; McDonnell SK; Rocca WA Neurology; 1999 Nov; 53(8):1858-60. PubMed ID: 10563640 [TBL] [Abstract][Full Text] [Related]
8. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden. Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139 [TBL] [Abstract][Full Text] [Related]
9. Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson's disease in the Chinese population. Wang L; Guo JF; Nie LL; Luo L; Zuo X; Shen L; Jiang H; Yan XX; Xia K; Pan Q; Tang BS J Clin Neurosci; 2011 Apr; 18(4):541-4. PubMed ID: 21315600 [TBL] [Abstract][Full Text] [Related]
10. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Lincoln S; Vaughan J; Wood N; Baker M; Adamson J; Gwinn-Hardy K; Lynch T; Hardy J; Farrer M Neuroreport; 1999 Feb; 10(2):427-9. PubMed ID: 10203348 [TBL] [Abstract][Full Text] [Related]
11. S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship. Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Corrèze JR; Delemotte B; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C Mov Disord; 2003 Feb; 18(2):130-7. PubMed ID: 12539205 [TBL] [Abstract][Full Text] [Related]
12. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Harhangi BS; Farrer MJ; Lincoln S; Bonifati V; Meco G; De Michele G; Brice A; Dürr A; Martinez M; Gasser T; Bereznai B; Vaughan JR; Wood NW; Hardy J; Oostra BA; Breteler MM Neurosci Lett; 1999 Jul; 270(1):1-4. PubMed ID: 10454131 [TBL] [Abstract][Full Text] [Related]
13. [Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson's disease in Shanghai]. Hao YX; Zhang J; Fang CP; Zhang Q; Zhang JR; Shen Q Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):272-5. PubMed ID: 18543214 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Wintermeyer P; Krüger R; Kuhn W; Müller T; Woitalla D; Berg D; Becker G; Leroy E; Polymeropoulos M; Berger K; Przuntek H; Schöls L; Epplen JT; Riess O Neuroreport; 2000 Jul; 11(10):2079-82. PubMed ID: 10923647 [TBL] [Abstract][Full Text] [Related]
15. [Association of the ubiquitin carboxy-terminal hydrolase-L1 genetic polymorphism with the susceptibility of Parkinson's disease]. Xiao Y; Zhang B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):586-7. PubMed ID: 18841579 [TBL] [Abstract][Full Text] [Related]
16. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1. Tse HS; Hu HY; Sze KH Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373 [TBL] [Abstract][Full Text] [Related]
17. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903 [TBL] [Abstract][Full Text] [Related]
18. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Nazé P; Vuillaume I; Destée A; Pasquier F; Sablonnière B Neurosci Lett; 2002 Aug; 328(1):1-4. PubMed ID: 12123845 [TBL] [Abstract][Full Text] [Related]
19. Case-control study of UCHL1 S18Y variant in Parkinson's disease. Tan EK; Puong KY; Fook-Chong S; Chua E; Shen H; Yuen Y; Pavanni R; Wong MC; Puvan K; Zhao Y Mov Disord; 2006 Oct; 21(10):1765-8. PubMed ID: 16941465 [TBL] [Abstract][Full Text] [Related]
20. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Liu Y; Fallon L; Lashuel HA; Liu Z; Lansbury PT Cell; 2002 Oct; 111(2):209-18. PubMed ID: 12408865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]